VTE Tagged Articles
New blood thinner Eliquis shows promising results in clinical trials
The new blood thinner Eliquis (apixaban) reduced the recurrence of blood clots and death by 80 percent with no increase in major bleeding, according to a study on long-term use of the drug.
Pradaxa safety issues cause delay in new blood thinner approval
Safety issues following the October 2010 approval by the Food and Drug Administration (FDA) of the blood thinner Pradaxa are being blamed for the three-month delay in the decision on a new blood thinner.
Why would FDA panel not ban Yaz over blood clot risk?
Why did an advisory panel of experts for the Food and Drug Administration (FDA) not vote to ban the popular birth control pill Yaz and other pills of its generation containing the hormone drospirenone, instead opting to recommend that the
FDA warns of elevated blood clot risk in Yaz birth control pills
Two new studies showing an increased risk in venous thromboembolism (VTE), or blood clots in the lungs, in women who use Yaz birth control pills and oral contraceptives with similar hormone formulations, has resulted in a special drug safety notification
Ortho Evra birth control patch warning upgraded to a black box warning
A new black box warning has been added to the safety label of Johnson & Johnson’s birth control patch Ortho Evra (norelgestromin/ethinyl estradiol), alerting consumers that women aged 15-44 who use the patch may be at greater risk for life-threatening
Women more at risk of blood clots during first six months on ‘The Pill’
Women who use birth control pills are at greater risk for developing blood clots during the first six months of oral contraceptive use, and they are at even greater risk when first starting the pill and when restarting the same